Slovakia: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
BirthWeeksMonthsYears
62346101214-1517451214-1518
Coronavirus disease (COVID-19)
COVID-193
tuberculosis
BCG4
diphtheria
D
D
D
D
d
tetanus
TT
TT
TT
TT
TT
pertussis
acP
acP
acP
acP
acP
poliomyelitis
IPV
IPV
IPV
IPV
IPV
Haemophilus influenzae type b infection
Hib
Hib
Hib
hepatitis B1
HepB5
HepB
HepB
HepB
pneumococcal disease1
PCV13
PCV13
PCV13
meningococcal disease
MenB
MenB
MCV4/MenB
MCV4/MenB6
measles
MEAS
MEAS
mumps
MUMPS
MUMPS
rubella
RUBE
RUBE
human papillomavirus infection
HPV (F/M)7
influenza2
IIV3

Version:


Footnotes:

  1. Vaccination is free of charge also for at-risk groups based on national legislation.
  2. Flu vaccine is mandatory for at-risk groups based on national legislation.
  3. https://korona.gov.sk/
  4. Free of charge only for children in defined at-risk groups.
  5. Babies born to a mother infected with hepatitis B will be offered a first dose at birth simultaneously with HB immunoglobulin, and two additional doses: one at 1 month and one at 6 months
  6. One dose of each vaccine if given between 14 and 15 years
  7. Gender-neutral (boys and girls) vaccination offered


More information available at:
https://www.ockovaniechrani.sk/ https://szu.cz/tema/vakciny-a-ockovani/


-------------------------------------------------------------------------------------------------------------------------------

MAJOR HISTORICAL CHANGES

Measles, mumps and rubella:
1969: Measles vaccine introduced into national childhood vaccination schedule for children aged 12 months
1974: Age for measles vaccination changed to 9 months
1977: Second dose of measles vaccine was introduced to 11 - 15 months old children
1982: Age of measles vaccination changed to 11 months for the first dose and to 18 - 22 months for the second dose. Rubella vaccination was introduced for 11 year- old seronegative girls
1984: Rubella vaccination was introduced for all 11 years old girls
1985: Age of measles vaccination changed to 14 months for the first dose and to 20 - 24 months for the second dose. Rubella vaccination was introduced for all 2 years old children
1987: Combined mumps and measles vaccine introduced into national childhood vaccination schedule at 14 months (first dose) and 20-24 months (second dose)
1990: Second dose vaccination against mumps and measles changed to 13 years
1992: Combined vaccine against measles, mumps and rubella was introduced into national childhood vaccination in schedule 14 months (first dose) and 13 years (second dose)
1995: Age of second MMR dose changed to 10 years
2020: Age of second MMR dose changed to 4 years.

Hepatitis B:
1998: HepB introduced
2004: HepB is given at 10 years of age
2008: Vaccination completed in ex-adolescents

Haemophilus influenza type b:
2000: Hib introduced

HPV:
2020: Gender-neutral (boys and girls) HPV vaccination offered free of charge

Poliomyelitis:
2005: IPV replaced OPV

Diphtheria and tetanus:
2004: Booster dose of Td introduced for children 12 years of age
2009: Booster dose introduced for adults every 15 years after the previous vaccination

Pertussis:
2010: July. Re-vaccination in 12 years old children with tetravalent vaccine dTap-IPV was implemented into the national childhood vaccination schedule replacing the trivalent vaccine dT-IPV.

Pneumococcal vaccine:
2008: April. PCV7 universally recommended to children less than 2 years old as complementary (optional) vaccination for optimal individual protection. Cost of vaccine is shared with 96% of cost reimbursed by the national health insurance. However, it is free of charge to children less than 2 years old belonging to risk groups
2009: January. PCV7 implemented into the national vaccination schedule as compulsory being fully reimbursed by the national health insurance
2010: July. PCV13 implemeted into the national childhood vaccination schedule replacing PCV7
2011: Two vaccines, PCV13 and PCV10, were decided to be used for mandatory vaccination

Tuberculossis:
2010: July. Re-vaccination of 10 year-old tuberculin-negative children was withdrawn from the national childhood vaccination schedule
2012: January. Vaccination of newborns against tuberculosis was cancelled



VACCINES RECOMMENDED FOR AT-RISK GROUPS:
HEALTHCARE WORKERS:
-- Tuberculosis (only tuberculin negative HCW before appointing to the Department of Tuberculosis and Respiratory Infections and Pathology, microbiologists and vets at high risk of infection)
-- Hepatitis B (HCW at high risk of infection, students of medical schools)
-- Hepatitis A (paediatricians, GPs, infectious disease specialists and gastroenterologists, employees of laboratories at high risk of infection)
-- Influenza (HCW in direct contact with patients)

BABIES/CHILDREN:
-- Hepatitis B (babies of HBsAg positive mothers, children placed in centers for drug addicted persons)
-- Hepatitis A (2 years old children living in poor hygienic conditions)
-- Influenza (children from 6th months up to 12 years)
-- HPV (for 12 years old girls and boys)

ELDERLY:
-- Hepatitis B (persons living in social care facilities for mentally ill people)
-- Influenza (persons in social care facilities, persons in the age of 59 years and older)
-- Pneumococcal disease (persons in social care facilities, persons in the age of 59 years and older)

PEOPLE REGARDLESS OF AGE WITH UNDERLYING CONDITIONS:
--Influenza(persons with serious chronic diseases of respiratory and cardiovascular system, with metabolic, renal disorders and disorders of immunity)
-- Ppneumococcal disease (persons with serious chronic diseases of respiratory and cardiovascular system, with metabolic, renal disorders and disorders of immunity)
-- Hepatitis B (persons with chronic disease of liver, diabetics, persons with cystic fibrosis)
-- Hepatitis A (persons with chronic disease of liver)

-------------------------------------------------------------------------------------------------------------------------------

Date of last update: 22 Jan. 2024

-------------------------------------------------------------------------------------------------------------------------------